{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:47:51Z","timestamp":1790279271924,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T00:00:00Z","timestamp":1513382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ophthalmos Research and Educational Institute"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.exer.2017.12.005","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T03:09:50Z","timestamp":1513393790000},"page":"128-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Omega-3 fatty acids protect retinal neurons in the DBA\/2J hereditary glaucoma mouse model"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9193-0574","authenticated-orcid":false,"given":"Maria","family":"Kalogerou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kolovos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekatherine","family":"Prokopiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2440-9789","authenticated-orcid":false,"given":"Gregory","family":"Papagregoriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5549-9169","authenticated-orcid":false,"given":"Constantinos","family":"Deltas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Malas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassos","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2017.12.005_bib1","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1167\/iovs.03-1123","article-title":"Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure","volume":"45","author":"Ahmed","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7007-4-20","article-title":"Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma","volume":"4","author":"Anderson","year":"2006","journal-title":"BMC Biol."},{"key":"10.1016\/j.exer.2017.12.005_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/ng794","article-title":"Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA\/2J mice","volume":"30","author":"Anderson","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2017.12.005_bib4","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1167\/iovs.07-1337","article-title":"Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA\/2J mouse model of glaucoma","volume":"49","author":"Bosco","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib5","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases","volume":"83","author":"Calder","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.exer.2017.12.005_bib6","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1167\/iovs.08-2205","article-title":"Manganese-enhanced MRI of the DBA\/2J mouse model of hereditary glaucoma","volume":"49","author":"Calkins","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00055735-199504000-00015","article-title":"Pathophysiology of pigment dispersion syndrome and pigmentary glaucoma","volume":"6","author":"Campbell","year":"1995","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0420.1998.tb00880.x","article-title":"Fatty acid use in glaucomatous optic neuropathy treatment","volume":"76","author":"Cellini","year":"1998","journal-title":"Acta Ophthalmol. Scand. Suppl."},{"key":"10.1016\/j.exer.2017.12.005_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/7741","article-title":"Interacting loci cause severe iris atrophy and glaucoma in DBA\/2J mice","volume":"21","author":"Chang","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2017.12.005_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lfs.2014.10.014","article-title":"Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor gamma activation","volume":"120","author":"Chang","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib11","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.1073\/pnas.1402819111","article-title":"Caspase-8 promotes NLRP1\/NLRP3 inflammasome activation and IL-1beta production in acute glaucoma","volume":"111","author":"Chi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2017.12.005_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcjo.2016.07.013","article-title":"Glaucoma treatment trends: a review","volume":"52","author":"Conlon","year":"2017","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1753-4887.1992.tb01286.x","article-title":"Essential fatty acids: the importance of n-3 fatty acids in the retina and brain","volume":"50","author":"Connor","year":"1992","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.exer.2017.12.005_bib14","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exer.2017.12.005_bib15","article-title":"Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide","author":"Dang","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.exer.2017.12.005_bib16","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1167\/iovs.02-1101","article-title":"Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA\/2NNia glaucomatous mice: comparison with RGC loss in aging C57\/BL6 mice","volume":"44","author":"Danias","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1471-4159.2009.06286.x","article-title":"Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration","volume":"110","author":"Ebert","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2017.12.005_bib18","first-page":"23","article-title":"Early involvement of immune\/inflammatory response genes in retinal degeneration in DBA\/2J mice","volume":"1","author":"Fan","year":"2010","journal-title":"Ophthalmol. Eye Dis."},{"key":"10.1016\/j.exer.2017.12.005_bib19","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1167\/iovs.05-0955","article-title":"Topographic and morphologic analyses of retinal ganglion cell loss in old DBA\/2NNia mice","volume":"47","author":"Filippopoulos","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1167\/iovs.12-11207","article-title":"Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia","volume":"54","author":"Galindo-Romero","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/aos.12629","article-title":"A two-year follow-up of oral antioxidant supplementation in primary open-angle glaucoma: an open-label, randomized, controlled trial","volume":"93","author":"Garcia-Medina","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib22","first-page":"205","article-title":"The new era of Omega-3 fatty acids supplementation: therapeutic effects on dry age-related macular degeneration","volume":"10","author":"Georgiou","year":"2015","journal-title":"J. Stem Cell."},{"key":"10.1016\/j.exer.2017.12.005_bib23","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1167\/iovs.16-20979","article-title":"Neuroprotective effects of omega-3 polyunsaturated fatty acids in a rat model of anterior ischemic optic neuropathy","volume":"58","author":"Georgiou","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1194\/jlr.P065540","article-title":"Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers","volume":"57","author":"Gorusupudi","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.exer.2017.12.005_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0253-7613.44151","article-title":"Recent advances in pharmacotherapy of glaucoma","volume":"40","author":"Gupta","year":"2008","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.exer.2017.12.005_bib27","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0008-4182(06)80012-8","article-title":"The evidence for efficacy of omega-3 fatty acids in preventing or slowing the progression of retinitis pigmentosa: a systematic review","volume":"41","author":"Hodge","year":"2006","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1083\/jcb.200506099","article-title":"Retinal ganglion cell degeneration is topological but not cell type specific in DBA\/2J mice","volume":"171","author":"Jakobs","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exer.2017.12.005_bib30","first-page":"951","article-title":"Essential iris atrophy, pigment dispersion, and glaucoma in DBA\/2J mice","volume":"39","author":"John","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ajcn\/79.5.755","article-title":"Dietary fat consumption and primary open-angle glaucoma","volume":"79","author":"Kang","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.exer.2017.12.005_bib32","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0039-6257(03)00007-9","article-title":"Retinal ganglion cells and neuroprotection for glaucoma","volume":"48","author":"Levin","year":"2003","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib33","article-title":"Neuroprotection for glaucoma: Requirements for clinical translation","author":"Levin","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2017.12.005_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/pros.23218","article-title":"Effect of dietary Omega-3 fatty acids on tumor-associated macrophages and prostate cancer progression","volume":"76","author":"Liang","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.exer.2017.12.005_bib36","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1194\/jlr.D500022-JLR200","article-title":"A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies","volume":"46","author":"Masood","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.exer.2017.12.005_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00055735-199704000-00006","article-title":"Glaucoma, apoptosis, and neuroprotection","volume":"8","author":"McKinnon","year":"1997","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jn\/121.4.547","article-title":"Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women","volume":"121","author":"Meydani","year":"1991","journal-title":"J. Nutr."},{"key":"10.1016\/j.exer.2017.12.005_bib39","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20022041","article-title":"By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA\/2J pigmentary glaucoma","volume":"197","author":"Mo","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.exer.2017.12.005_bib40","article-title":"Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase","volume":"1-11","author":"Mori","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.exer.2017.12.005_bib41","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1523\/JNEUROSCI.2801-06.2006","article-title":"Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma","volume":"26","author":"Nakazawa","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2017.12.005_bib42","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.117.8.1050","article-title":"Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma","volume":"117","author":"Neufeld","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib43","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1167\/iovs.06-0585","article-title":"Dietary omega 3 fatty acids decrease intraocular pressure with age by increasing aqueous outflow","volume":"48","author":"Nguyen","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib44","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.08-1735","article-title":"Dietary omega-3 fatty acids and ganglion cell function","volume":"49","author":"Nguyen","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/IJG.0b013e318237cac7","article-title":"Dietary omega-3 deficiency and IOP insult are additive risk factors for ganglion cell dysfunction","volume":"22","author":"Nguyen","year":"2013","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.exer.2017.12.005_bib46","first-page":"6462120","article-title":"Omega-3 fatty acids: possible neuroprotective mechanisms in the model of global ischemia in rats","volume":"2016","author":"Nobre","year":"2016","journal-title":"J. Nutr. Med."},{"key":"10.1016\/j.exer.2017.12.005_bib47","first-page":"115","article-title":"Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids","volume":"64","author":"Nowak","year":"2010","journal-title":"Postepy. Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.exer.2017.12.005_bib48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.exer.2016.06.001","article-title":"Increased production of omega-3 fatty acids protects retinal ganglion cells after optic nerve injury in mice","volume":"148","author":"Peng","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2017.12.005_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.exer.2014.02.022","article-title":"Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma","volume":"122","author":"P\u00e9rez de Lara","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2017.12.005_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2016-000056","article-title":"Therapeutic potential of omega-3 fatty acids supplementation in a mouse model of dry macular degeneration","volume":"1","author":"Prokopiou","year":"2017","journal-title":"BMJ Open Ophth."},{"key":"10.1016\/j.exer.2017.12.005_bib51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199304153281507","article-title":"Open-angle glaucoma","volume":"328","author":"Quigley","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2017.12.005_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1350-9462(98)00014-7","article-title":"Neuronal death in glaucoma","volume":"18","author":"Quigley","year":"1999","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2017.12.005_bib53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/ICU.0b013e32834ff490","article-title":"Clinical trials for glaucoma neuroprotection are not impossible","volume":"23","author":"Quigley","year":"2012","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib54","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib55","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3945\/jn.112.169649","article-title":"Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2\/Cx3cr1-deficient mice on Crb1rd8 background","volume":"143","author":"Ramkumar","year":"2013","journal-title":"J. Nutr."},{"key":"10.1016\/j.exer.2017.12.005_bib56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.plefa.2005.11.007","article-title":"Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids","volume":"74","author":"Ren","year":"2006","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.exer.2017.12.005_bib57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1755-3768.2011.02356.x","article-title":"Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study","volume":"91","author":"Renard","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00059-004-2602-4","article-title":"Risk stratification by the \"EPA+DHA level\" and the \"EPA\/AA ratio\" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids","volume":"29","author":"Rupp","year":"2004","journal-title":"Herz"},{"key":"10.1016\/j.exer.2017.12.005_bib59","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1167\/iovs.07-0483","article-title":"Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA\/2J mouse model of glaucoma","volume":"48","author":"Saleh","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.visres.2008.09.029","article-title":"A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats","volume":"49","author":"Salinas-Navarro","year":"2009","journal-title":"Vis. Res."},{"issue":"66","key":"10.1016\/j.exer.2017.12.005_bib61","article-title":"Progressive ganglion cell loss and optic nerve degeneration in DBA\/2J mice is variable and asymmetric","volume":"7","author":"Schlamp","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.exer.2017.12.005_bib62","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nutres.2011.03.011","article-title":"Dietary polyunsaturated fatty acids reduce retinal stress induced by an elevation of intraocular pressure in rats","volume":"31","author":"Schnebelen","year":"2011","journal-title":"Nutr. Res."},{"key":"10.1016\/j.exer.2017.12.005_bib63","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00417-009-1094-6","article-title":"A dietary combination of omega-3 and omega-6 polyunsaturated fatty acids is more efficient than single supplementations in the prevention of retinal damage induced by elevation of intraocular pressure in rats","volume":"247","author":"Schnebelen","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib64","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/S0042-6989(02)00188-8","article-title":"Effects of anti-glaucoma medications on ganglion cell survival: the DBA\/2J mouse model","volume":"42","author":"Schuettauf","year":"2002","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2017.12.005_bib66","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1001\/archopht.121.12.1728","article-title":"Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake","volume":"121","author":"Seddon","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib67","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.119.8.1191","article-title":"Dietary fat and risk for advanced age-related macular degeneration","volume":"119","author":"Seddon","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib68","article-title":"Neuroprotection for treatment of glaucoma in adults","volume":"1","author":"Sena","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.exer.2017.12.005_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exer.2017.12.005_bib70","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coph.2013.05.012","article-title":"Resolution phase lipid mediators of inflammation: agonists of resolution","volume":"13","author":"Serhan","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.exer.2017.12.005_bib71","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11745-004-1339-7","article-title":"Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers","volume":"39","author":"Serhan","year":"2004","journal-title":"Lipids"},{"key":"10.1016\/j.exer.2017.12.005_bib72","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuroscience.2016.08.013","article-title":"Omega-3 fatty acid supplement prevents development of intracranial atherosclerosis","volume":"334","author":"Shen","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2017.12.005_bib73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archopht.118.3.401","article-title":"Dietary fat and fish intake and age-related maculopathy","volume":"118","author":"Smith","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1529-1839(04)70023-8","article-title":"Pigment dispersion syndrome and pigmentary glaucoma","volume":"75","author":"Sowka","year":"2004","journal-title":"Optometry"},{"key":"10.1016\/j.exer.2017.12.005_bib75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2013.10.006","article-title":"Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases","volume":"19","author":"Spite","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.exer.2017.12.005_bib76","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/OPTH.S96433","article-title":"Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study","volume":"10","author":"Tellez-Vazquez","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib77","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1167\/iovs.02-1136","article-title":"Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma","volume":"44","author":"Tezel","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib78","first-page":"1787","article-title":"TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes","volume":"42","author":"Tezel","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib79","first-page":"2109","article-title":"Current perspective of neuroprotection and glaucoma","volume":"9","author":"Tian","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib80","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.4049\/jimmunol.1100225","article-title":"Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype","volume":"187","author":"Titos","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2017.12.005_bib81","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2353\/ajpath.2009.090089","article-title":"A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration","volume":"175","author":"Tuo","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2017.12.005_bib82","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.4103\/0301-4738.73700","article-title":"Neuroprotection in glaucoma","volume":"59","author":"Vasudevan","year":"2011","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2011.08.001","article-title":"Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas","volume":"31","author":"Vidal-Sanz","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2017.12.005_bib84","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.survophthal.2012.08.010","article-title":"The role of inflammation in the pathogenesis of glaucoma","volume":"58","author":"Vohra","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib85","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1006\/cyto.2000.0735","article-title":"Activation state alters the effect of dietary fatty acids on pro-inflammatory mediator production by murine macrophages","volume":"12","author":"Wallace","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.exer.2017.12.005_bib86","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/IJG.0000000000000200","article-title":"Retinal microglia in glaucoma","volume":"25","author":"Wang","year":"2016","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.exer.2017.12.005_bib87","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1167\/iovs.12-10020","article-title":"A neurobehavioral analysis of the prevention of visual impairment in the DBA\/2J mouse model of glaucoma","volume":"53","author":"Wong","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.12.005_bib88","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archopht.118.5.666","article-title":"Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head","volume":"118","author":"Yan","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2017.12.005_bib89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3","article-title":"Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head","volume":"32","author":"Yuan","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.exer.2017.12.005_bib90","doi-asserted-by":"crossref","first-page":"31240","DOI":"10.1074\/jbc.M502641200","article-title":"Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma","volume":"280","author":"Zhou","year":"2005","journal-title":"J. Biol. Chem."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483517303056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483517303056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T07:32:32Z","timestamp":1530862352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483517303056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":88,"alternative-id":["S0014483517303056"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2017.12.005","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 fatty acids protect retinal neurons in the DBA\/2J hereditary glaucoma mouse model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2017.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}